Delving into the Latest Updates on Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd. with Synapse

Overview

Tags

Infectious Diseases

Hemic and Lymphatic Diseases

Neoplasms

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	2
Nervous System Diseases	1
Hemic and Lymphatic Diseases	1
Neoplasms	1
Immune System Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	3

Top 5 Target	Count

SCNA(Sodium voltage-gated channel alpha subunits)	1
Bcr-Abl(Bcr-Abl tyrosine kinase)	1
Ergosterol	1

The main purpose of this study is to investigate the tolerability and safety of a single oral administration of Meditinib sulfate tablets in subjects with newly diagnosed chronic myeloid leukemia in the chronic phase; the secondary purpose is to investigate the human pharmacokinetic characteristics of a single oral administration of Meditinib sulfate tablets in subjects with newly diagnosed chronic myeloid leukemia in the chronic phase.

Start Date08 Sep 2016

Sponsor / Collaborator

Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.

[+2]

CTR20130309

/ Active, not recruitingPhase 2

评价硝酸芬替康唑栓的有效性和安全性的多中心、随机、盲法、阳性药物平行对照II期临床试验

[Translation] A multicenter, randomized, blinded, positive drug parallel controlled phase II clinical trial to evaluate the efficacy and safety of fenticonazole nitrate suppositories

评价硝酸芬替康唑栓治疗外阴阴道念珠菌病的有效性和安全性，探索硝酸芬替康唑栓治疗外阴阴道念珠菌病的临床使用剂量。

[Translation]

To evaluate the efficacy and safety of fenticonazole nitrate suppositories in the treatment of vulvovaginal candidiasis and to explore the clinical dosage of fenticonazole nitrate suppositories in the treatment of vulvovaginal candidiasis.

Start Date05 Aug 2014

Sponsor / Collaborator

Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.

CTR20130250

/ Active, not recruitingPhase 1

硝酸芬替康唑栓临床药代动力学试验

[Translation] Clinical Pharmacokinetics of Fenticonazole Nitrate Suppositories

了解新药在人体内的吸收、分布与消除规律，为临床试验制订合理的给药方案提供依据。

[Translation]

Understand the absorption, distribution and elimination patterns of new drugs in the human body and provide a basis for formulating reasonable dosing plans for clinical trials.

Start Date-

Sponsor / Collaborator

Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.

100 Clinical Results associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.

Login to view more data

0 Patents (Medical) associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.

Login to view more data

100 Deals associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Phase 2

Phase 3

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Ambroxol Hydrochloride ( SCNA )	Lower Respiratory Tract Infections More	Phase 3
Fenticonazole Nitrate ( Ergosterol )	Candidiasis, Vulvovaginal More	Phase 2
Meditinib Sulfate ( Bcr-Abl )	Philadelphia chromosome positive chronic myelogenous leukemia More	Phase 1